Home/Filings/4/0001104659-13-037149
4//SEC Filing

CARE CAPITAL II LLC 4

Accession 0001104659-13-037149

CIK 0000786947other

Filed

May 2, 8:00 PM ET

Accepted

May 3, 4:15 PM ET

Size

11.9 KB

Accession

0001104659-13-037149

Insider Transaction Report

Form 4
Period: 2013-05-01
Transactions
  • Sale

    Common Stock

    2013-05-01$2.40/sh95,000$228,0007,814,067 total(indirect: See Footnote)
  • Sale

    Common Stock

    2013-05-02$2.47/sh95,000$234,6507,719,067 total(indirect: See Footnote)
Transactions
  • Sale

    Common Stock

    2013-05-01$2.40/sh95,000$228,0007,814,067 total(indirect: See Footnote)
  • Sale

    Common Stock

    2013-05-02$2.47/sh95,000$234,6507,719,067 total(indirect: See Footnote)
Transactions
  • Sale

    Common Stock

    2013-05-01$2.40/sh95,000$228,0007,814,067 total(indirect: See Footnote)
  • Sale

    Common Stock

    2013-05-02$2.47/sh95,000$234,6507,719,067 total(indirect: See Footnote)
Footnotes (6)
  • [F1]The shares were sold as follows: 88,900 by Care Capital Investments II, LP and 6,100 by Care Capital Offshore Investments II, L.P.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.37, inclusive. The reporting person undertakes to provide to Acura Pharmaceuticals, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (5) to this Form 4.
  • [F3]Consists of 7,312,415 shares held by Care Capital Investments II, LP and 501,652 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.
  • [F4]The shares were sold as follows: 88,900 by Care Capital Investments II, LP and 6,100 by Care Capital Offshore Investments II, L.P.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.39, inclusive.
  • [F6]Consists of 7,223,515 shares held by Care Capital Investments II, LP and 495,552 shares held by Care Capital Offshore Investments II, L.P. Care Capital II, LLC is the general partner of Care Capital Investments II, LP and Care Capital Offshore Investments II, LP and as a result, Care Capital II, LLC has the ultimate power to vote or direct the vote and to dispose or direct the disposition of such shares. Care Capital II, LLC is managed by three or more members and accordingly none of the managing members is deemed to have voting or dispositive control over the securities.

Documents

1 file

Issuer

ACURA PHARMACEUTICALS, INC

CIK 0000786947

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001212648

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:15 PM ET
Size
11.9 KB